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Background: TGF- induces apoptosis in Burkitt’s lymphoma cells.
Results: PUMA is a direct target gene of TGF- signaling and is required for rapid apoptosis.
Conclusion: TGF--mediated direct induction of PUMA contributes to apoptosis in human and murine c-Myc-driven
lymphomas.
Significance: These studies link TGF- signaling and transcriptional activation of PUMA, two factors with critical roles in
regulating B-cell survival.
c-Myc transformed human Burkitt’s lymphoma (BL) cells are
highly sensitive to TGF--induced apoptosis. Previously we
demonstrated that TGF--mediated cell death in BL cells is reg-
ulated via themitochondrial intrinsic apoptosis pathway, which
is dependent on the activation of BAX and/or BAK. TGF-
directly induces transcription of the BH3-only protein BIK and
represses expression of the pro-survival factor BCL-XL but has
no effect on the direct BAX/BAK “activators” BIM or BID
(tBID). Here we show that TGF- induces the BH3-only activa-
tor PUMA to aid induction of the intrinsic cell death pathway.
TGF- also induced PUMA in normal germinal center CD77-
positive centroblasts isolated from human tonsil tissue. PUMA
was a direct TGF- target gene in B-cells, and we identify a
putative Smad-binding region within the human PUMA pro-
moter that recruits Smad3 and Smad4 in cells in response to
TGF- signaling. Constitutive activity of the isolated Smad-
binding region in luciferase reporter assays was dependent on
Smad consensus sequences and was partially dependent on
endogenousTGF- signaling andSmad4.KnockdownofPUMA
in BL cells using lentiviral shRNA resulted in slower kinetics of
the TGF--mediated apoptotic response. Analysis of E-Myc
cell lines demonstrated that c-myc-driven murine lymphomas
are also sensitive to TGF--mediated apoptosis. Moreover,
Puma/ E-Myc lines demonstrated significantly delayed
kinetics of the apoptotic response when compared with wild
type lymphomas. TGF- therefore induces a polygenic response
in Myc-driven lymphomas involving transcription of PUMA,
which is necessary for the rapid induction of cell death.
TGF- is a potent immune regulator, controlling the differ-
entiation, function, and survival of hemopoietic cells including
B- and T-cells (1). Control of B-cell homeostasis is mediated
through the TGF--dependent regulation of cell cycle arrest
and apoptosis.We have previously shown that TGF- signaling
contributes to “death by neglect” of spontaneously apoptosing
human germinal center centroblasts, as well as inducing apo-
ptosis of malignant lymphomas derived from the germinal cen-
ter B-cells (c-Myc transformed Burkitt’s lymphoma (BL)5 cells)
(2, 3). This apoptosis program is induced by the intracellular
signaling cascades activated by the binding of TGF- to the
high affinity TGF- type II receptor. Binding of ligand to the
TGF- type II receptor enables the formation of a heterotetra-
meric complex between the constitutively active serine/threonine
kinase type II receptor and the type I receptor, ALK5. The TGF-
type II receptor phosphorylates and activates ALK5, thereby
inducing the canonical Smad pathway and/or several non-Smad
pathways (4, 5). ALK5 activation results in C-terminal phosphor-
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ylationof the receptor-regulatedSmads, Smad2 (Ser-465/476) and
Smad3 (Ser-433/435), which then bind to the co-Smad, Smad4.
The resulting heteroligomeric Smad complexes accumulate
within the nucleus to control expression of genes involved in
the regulation of cell survival and apoptosis (6).
In BL cells, TGF--induced apoptosis is associated with
changes in expression levels of apoptosis regulators upstream
of BAX and BAK. Activated BAX and BAK homo-oligomerize
in the mitochondrial membrane to cause mitochondrial outer
membrane permeabilization (7) and the release of pro-apo-
ptotic factors. The function of BAX and BAK is tightly regu-
lated by the BCL-2 family of proteins, including the pro-sur-
vival factors BCL-2 and its homologues, BCL-XL, MCL-1,
BFL-1, BOO, and BCL-w. Other members of the family share
one region of homology with BCL-2 (BH3-only proteins), are
pro-apoptotic, and include BIK, PUMA, BID, NOXA, BIM,
BAD, HRK, and BMF. The “activators” of BAX and BAK (8)
include BIM, tBID, and PUMA (8–10), which are proposed to
directly bind to BAX and BAK in response to apoptotic stimuli.
The pro-survival factors such as BCL-2 prevent apoptosis by
sequestering the activator proteins, but they themselvesmay be
inhibited by selective interaction with BH3-only proteins (11).
These proteins are therefore referred to as apoptosis “sensitiz-
ers,” which may either liberate activators from the pro-survival
factors to enable BAX/BAK activation (12) or, alternatively,
block the direct interaction of pro-survival factors with BAX
and BAK (13).
Of these BCL-2 family members, TGF- induces Smad-de-
pendent transcription of the sensitizer BIK and down-regula-
tion of the pro-survival factor BCL-XL in BL cells (3), however,
no regulation of the activators BIM or tBID was evident during
initiation of the apoptosis program. PUMA (p53-up-regulated
modulator of apoptosis) is therefore the only other direct BAX/
BAK activator that may have a role in promoting TGF--in-
duced apoptosis in this system. PUMA physically associates
with BAX via its BH3 domain (residues 127–150) to induce an
apoptotic change in conformation of BAX (10), as well as pro-
moting BAX-dependent apoptosis by dissociating BCL-XL
from BAX (10, 14). PUMA is transcriptionally regulated by the
p53 family (15–17), NF-B (18), and E2F-1 (19), by activated
FOXO3a following cytokine withdrawal (20) and in response to
calcium pool depletion of the endoplasmic reticulum (21).
The tumor suppressor functions of p53 are rate-limiting for
lymphomagenesis in E-Myc murine models of BL. PUMA
plays a major role in both p53-mediated and p53-independent
cell death (22, 23) and is required for oncogene-induced cell
death caused by c-Myc overexpression (22, 24). Consequently,
genetic deletion of Puma accelerates the development of
E-Myc lymphomas (24), and the p53/PUMA pathway is often
disrupted in E-Myc and BL lymphomas, either bymutation or
silencing of p53, by disruption of key p53 regulators (p19ARF
and MDM2) (25), or by epigenetic silencing of PUMA itself
(24). PUMA is also elevated in activated human and murine
primary B-cells and is involved in the regulation of mature
B-cell survival following T-cell-dependent B-cell response to
antigen (26).
Because activation of PUMA effectively limits lymphom-
agenesis, in this studywe investigate whether PUMA is a down-
stream effector of TGF--induced apoptosis of human and
murine c-Myc driven lymphomas. We identify PUMA as a
novel direct target of TGF- signaling in B-cells that mediates
rapid induction of apoptosis in response to TGF-.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents—BL cell lines were maintained in
RPMI 1640 (Invitrogen) supplemented with 5–10% (v/v) heat-
inactivated FCS, 2 mM glutamine, and antibiotics. Murine
E-Myc lymphoma lines were generated as detailed previously
(27) andmaintained inDMEM(Invitrogen) supplementedwith
10% heat-inactivated FCS, 2 mM glutamine (Invitrogen), 1 mM
pyruvate (Invitrogen), 50 M -mercaptoethanol (Sigma), 200
M asparagine (Sigma), and antibiotics. Analyses were per-
formed on four cell lines derived from four independent
E-Myc lymphomas isolated from Puma/mice and on four
cell lines derived from four independent E-Myc lymphomas
isolated fromPuma/mice. The cells were treated as required
with 1–5 ng/ml TGF-1 (Peprotech), 50MZ-VAD.FMK (Cal-
biochem), 5 g/ml etoposide (Sigma), or 10 M SB-431542
(Tocris). Protein synthesis inhibition was carried out by prein-
cubation for 2 h with 50 g/ml cycloheximide and 100 M ani-
somycin (Sigma). Inhibition of transcription was carried out by
pretreatment of cells for 1 h with 2.5 g/ml actinomycin D
(Sigma). Inhibition of c-Myc activity was carried out by treat-
ment of cells with 25 M of the c-Myc selective inhibitor
10058-F4 (5-[(4-ethylphenyl) methylene]-2-thioxo-4-thiazo-
lidinone) (Sigma).
Transient Transfection of CA46 BL Cells—5 106 CA46 BL
cells were transfected in triplicate with 3 g of firefly luciferase
reporter plasmid and 1g of Renilla luciferase or -galactosid-
ase expression plasmids as internal controls for transfection
efficiency using an Amaxa nucleofector (solution T, program
A-23) as recommended by the manufacturer. Treatment with
SB-431542 (10 M) or solvent vehicle was carried out after
transfection if required. Transfected cells were incubated over-
night before being treated with TGF- (5 ng/ml) for 6 h. The
ratio of firefly/Renilla luciferase activity was determined using
the dual luciferase assay system (Promega) and expressed as the
means  S.D. ratio relative to untreated control samples. The
Smad4 shRNA plasmid (TRC 40028) was obtained from Open
Biosystems.
Isolation of Centroblasts—CD77ve cells were purified as
described previously (3). Following isolation, the cells were
incubated with or without TGF- in the presence of
z-VAD-fmk.
Immunoblotting and Antibodies—Radioimmune precipita-
tion assay lysateswere analyzed by SDS-PAGE.Antibodies used
in Western blotting were mouse monoclonals against PARP
(BD Biosciences); Smad2/3 (BD Biosciences); actin (Sigma);
rabbit polyclonal antibodies recognizing phospho-Smad 2 (Ser-
465/476), phospho-Smad3 (Ser-433/435), and PUMA (Cell Sig-
naling/Enzo Life Sciences); and a rabbit monoclonal against
Tubulin (Cell Signaling). Secondary HRP-conjugated antibod-
ies were obtained fromDako/GE Biosciences. Bound immuno-
complexes were detected by enhanced chemiluminescence
(ECL; AmershamBiosciences) or Immobilon western chemilu-
minescent substrate (Millipore).
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Analysis of Apoptosis by Flow Cytometry—The cells were
fixed in 80% ethanol, labeled with propidium iodide and ana-
lyzed by flow cytometry for less than 2 N DNA content. Murine
lymphoma lines were stained with FITC-conjugated annexin V
(1 g/ml, kindly provided by Dr. P. Duriez) and propidium
iodide (5 g/ml) in binding buffer (10 mM HEPES, pH 7.4, 140
mM NaCl, 2.5 mM CaCl2) and analyzed by flow cytometry.
Lentiviral Infection of BL Cell Lines—HEK293FT cells were
co-transfected with lentiviral packaging plasmids and pLKO.1-
based shRNA constructs (TRC 33610 or TRC 33613; Open Bio-
systems, termed sh1 and sh2). Lentivirus-containing superna-
tantswere collected, filtered, pooled, and used to infect BL cells.
After 48 h, the cells were selected in 0.4 g/ml puromycin. The
resulting stably transduced BL30 cells were routinely passaged
in growth medium (RPMI 1640 plus 20% FCS) containing 0.6
g/ml puromycin. Experiments to analyze TGF--induced
apoptosis were carried out in the absence of selection medium.
Retroviral Infection of Murine E-Myc Lymphoma Lines—
Ecotropic Phoenix cells were treated with 5 M chloroquine 30
min prior to calcium: phosphate precipitation-mediated trans-
fection with the pMIH vector (modified pMIG, GFP cassette
exchanged for hygromycin resistance) encoding a human
BCL-2 transgene, or vector alone, alongside the helper vector
pCL.Eco. After 48 h, virus-containing supernatants were
removed and filtered, and Polybrene was added to 4 g/ml.
E-Myc lymphomas were plated at 6  105 cells/well in a
12-well plate, and 1.5 ml of virus-containing medium was
applied. The plates were centrifuged at 480 g at 37 °C for 45
min. Selection was then carried out using 250 g/ml hygromy-
cin for 7 days. Subsequently, BCL-2 expression levels were ana-
lyzed by flow cytometry and Western blot.
qRT-PCR—Total cell RNA was isolated using TRIzol as rec-
ommended by the manufacturer. cDNA and qRT-PCRs were
prepared using SYBR green two-step qRT-PCR kits
(Finnzymes) and specific primers for each gene (Qiagen).
Amplified products were analyzed byChromo4 continuous flu-
orescence detector and Opticon Monitor3 software. The rela-
tive amount of RNA for each gene is expressed after normaliza-
tion to the amount of 18 S rRNA in each sample. RNA isolated
from murine lymphomas was converted to cDNA using a first
strand synthesis RT-PCR kit (Invitrogen). Quantitative PCRs
were performed using qPCR Supermix-UND (Invitrogen) and
TaqMan gene-specific primers (Applied Biosystems). Amplifi-
cation and analysis was achieved via use of a C1000 thermal
cycler fitted with a CFX96 fluorescence detector (Bio-Rad) and
CFX96 manager software (Bio-Rad).
ChIP Assay—2  107 CA46 cells were treated with 1 ng/ml
TGF- for 1 h and fixed in 1% formaldehyde for 15 min. The
formaldehyde was quenched with glycine, the cells were
washed in PBS, and nuclear extracts were prepared. The
extracts were sonicated to fragment the DNA and incubated
overnight with 20 ng of goat anti-Smad3 or 4 (Santa Cruz) or
isotype-matched control antibodies. Immune complexes were
captured using anti-goat IgG-coated agarose beads, the sam-
ples were washed, and the DNA was eluted off the beads. DNA
cross-links were reversed by incubation at 65 °C in 0.3 M NaCl,
and the samples were then digested with proteinase K. DNA
was extracted using phenol/chloroform and ethanol-precipi-
tated. PCRs using specific primers for human PUMA (5-
AGACTTGCTTGAACCCAGGA-3 and 5-AATCGCCT-
CACCAGAGTGAC-3) were performed for 35–50 cycles, and
the PCR products were analyzed on 2% agarose gels stained
with SYBR Green.
RESULTS
TGF- Induces the BH3-only Activator PUMA—We previ-
ously showed that TGF- treatment of BL cells results in the
transcriptional regulation of members of the BCL-2 family of
apoptosis regulators including BIK and BCL-XL (3). Analysis of
other BH3-only proteins thatmight contribute to the apoptotic
program induced by TGF- was carried out on subsequent
TGF- treatment time courses (Fig. 1). Apoptosis was evident,
as detected by Western blotting for cleavage of the caspase-3
substrate PARP, as early as 6–8 h after TGF- addition (Fig.
1A). During this period, the induction of BIK mRNA was con-
firmed; however, we also detected a transient increase in tran-
scripts of the apoptosis activator PUMA (Fig. 1B). There was no
concurrent increase in expression levels of the apoptosis sensi-
FIGURE 1. Transcripts of PUMA and BIK are elevated in TGF--treated
RamosBL cells.A, time course of TGF--induced apoptosis in humanBL cells
(Ramos). The cells were treated with 1 ng/ml TGF- for the times indicated.
Radioimmune precipitation assay lysates were analyzed byWestern blotting
for TGF- signaling (phosphorylation of Smad2 and Smad3) and apoptosis
(cleavage of PARP). A Western blot for total Smad2/3 is included as a loading
control. B, quantitative real time qRT-PCR analysis of BH3-only members of
the BCL-2 family in TGF--treated Ramos cells. The mean ( S.D.) fold
increases relative to untreated cells (set at 1) are shown.
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tizers, NOXA, BAD, HRK, or BMF. The induction of PUMA
mRNA in response to exogenous TGF- addition was con-
firmed across a panel of BL cell lines (Fig. 2A) and at the level of
protein expression (Fig. 2B). The Western blot analysis shown
in Fig. 2B indicates that the  isoform but not the  isoform of
PUMA was induced in response to TGF- signaling.
BLs are derived from centroblasts within the germinal cen-
ters of secondary lymphoid tissue. By isolating CD77-positive
centroblasts from human tonsil tissue (as described in Ref. 3),
we were able to demonstrate a small but consistent increase in
PUMA mRNA expression in TGF- treated cells relative to
untreated controls. No comparable increase in eitherNOXA or
HRKmRNA expression was evident (Fig. 2C). Increased abun-
dance of PUMA RNA transcripts in the presence of TGF-was
also evident throughout a 24-h time course of treatment of
CD77-positive primary cells (Fig. 2D). PUMA can therefore be
induced in response to TGF- in both BL cell lines and in the
cell of origin isolated from primary tissue. Induction of PUMA
mRNA in response to exogenous TGF- addition could also be
detected in the pro-B-cell line RS4;11, but not in non-B-cell
lineages including mouse embryo fibroblasts and HaCaT epi-
thelial cells (data not shown).
PUMA Is a Direct Target Gene of TGF- Signaling in Human
B-cells—We next investigated the mechanism of TGF--medi-
ated regulation of PUMA expression first by testing whether
PUMA is an immediate early target of TGF- signaling. BL cells
were pretreated with cycloheximide and anisomycin and were
subsequently treated with exogenous TGF- for the times indi-
cated. Induction of PUMA occurred even in the absence of de
novo protein synthesis (Fig. 3A), but blocking transcription
with actinomycinD resulted in the complete ablation of PUMA
mRNA induction (Fig. 3B). c-Myc overexpression is character-
istic of BL cells, and c-Myc itself is known to repress PUMA
transcription following growth factor stimulation (28). We
tested the effect of c-Myc overexpression on TGF--induced
activation of PUMA by pretreating BL cells with the c-Myc
inhibitor 10058-F4 at concentrations previously shown to
induce BL cell death (29). Inhibition of c-Myc modestly
increased basal PUMA transcription (especially in L3055 cells)
but did not significantly affect PUMA induction in response to
TGF- (Fig. 3C). Our data indicate that PUMA is a direct target
of TGF- signaling and, as such, implies that PUMA transcrip-
tion is likely to be regulated by Smad complexes binding to a
cognate binding element within the gene promoter. Smad-
FIGURE 2. PUMA is induced by TGF- in human BL cell lines and in normal tonsil CD77-positive B-cells. A, real time qRT-PCR analysis of PUMA in a panel
of TGF- responsive BL cell lines following 2 h of treatment. Themean ( S.D.) fold increase above background (set at 1 in untreated cells) is shown. B, Western
blot analysis of radioimmune precipitation assay extracts from BL cells either untreated or treatedwith TGF- for 2–8 h. Immunoreactive bands showing both
the TGF--inducible PUMA- (23 kDa) and PUMA- isoforms are indicated. AWestern blot for total Smad2/3 is included as a loading control. C andD, real time
qRT-PCRanalysis of RNA isolated fromhumanprimaryCD77-positive tonsil B-cells treatedwith z-VAD.FMKandTGF- for 2h (C) andover anextended24-h time
course of TGF- treatment (D). Themean ( S.D.) fold TGF--induced increase in normalized RNA expression comparedwith untreated cells (set at 1) is shown
(C). The mean ( S.D.) relative levels of PUMA RNA normalized to 18 S are shown in D.
TGF- Induces PUMA inMyc-driven Lymphomas
FEBRUARY 15, 2013•VOLUME 288•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 5201
 at G
lasgow
 U
niversity Library on January 29, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
binding regions (SBRs) frequently contain two copies of the
Smad-binding element (SBE) sequence 5-GTCT-3 or its
reverse complement 5-AGAC-3 (30). We identified a poten-
tial SBR (5-agactctgtct-3) (Fig. 3D) 1.9 kb upstream of the
PUMA transcription start site, contained within a region of the
promoter bearing striking homology to the SBR we previously
identified within the human BIK promoter (Fig. 3D and Ref. 3).
ChIP analysis using primers spanning this region demonstrated
TGF--dependent binding of Smads 3 and 4 to the endogenous
PUMA promoter in vivo (Fig. 3E).
We next analyzed the activity of a luciferase promoter
reporter construct containing2 kb of the 5 region upstream
of the PUMA transcription start site (31). The PUMA promoter
construct was constitutively active in CA46 BL cells and could
not be further induced by the addition of exogenous TGF-
(Fig. 4A), suggesting that the endogenous level of TGF- sig-
naling in these cellsmay be sufficient formaximal activity of the
isolated promoter region. We therefore tested whether inhibi-
tion of basal TGF- signaling using 10Mof theALK5 inhibitor
SB-431542 would affect PUMA promoter activity (Fig. 4B). We
observed an approximate 50% decrease in luciferase activity
following SB-431542 treatment, indicating that TGF- signal-
ing is required for maximal promoter activity.
To examine the activity of the potential Smad-binding region
more directly, we generated firefly luciferase reporter con-
structs containing concatemerized (2) versions of wild type
FIGURE 3. TGF- directly regulates hPUMA transcription and induces recruitment of activated Smad complexes to the hPUMA promoter. A, real time
qRT-PCR for PUMA expression in CA46 cells treated with or without TGF- and the protein synthesis inhibitors cycloheximide and anisomycin (CA) as
indicated. The cells were pretreated with cycloheximide and anisomycin for 2 h, and TGF-was added at 0 h. The mean ( S.D.) PUMA RNA expression levels
relative to the 2-h untreated sample is shown (2-h untreated sample valuewas set at 1). The fold induction relative to the untreated sample at each time point
is shown. B, real time qRT-PCR for PUMA expression in CA46 cells untreated or pretreated for 1 hwith the transcription inhibitor actinomycinD (ActD), followed
by a time course of TGF- treatment. RNA expression is expressed relative to the levels detected in the 2-h untreated sample (assigned a value of 1). C, a panel
of BL cell lines was pretreated for 30 min with 25 M of the c-Myc inhibitor (Myc i) 10058-F4 followed by 2 h of TGF- treatment (1 ng/ml). RNA was extracted
and analyzed by qPCR for PUMA expression. Expression levels were normalized to the internal standard 18 S RNA and are shown as the mean ( S.D.) fold
expression level relative to untreated controls (set at 1). D, sequence of a known SBR within the human BIK promoter (3) compared with a putative Smad-
binding element within the human PUMA promoter. The putative PUMA SBR at position 1923 to 1885 was analyzed by ChIP using specific primers
encompassing this region. E, ChIP assay for Smad recruitment to the endogenous PUMA promoter in CA46 cells culturedwith andwithout TGF- for 1 h. Input
lanes are from 10% of samples used in the IPs performed with control IgG, Smad3, and Smad4 antibodies.
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and mutant sequences shown in Fig. 4C. Consistent with the
2-kb promoter fragment, the 2 wild type SBE sequence was
active in CA46 cells. This activity was dependent on the con-
sensus SBEs because mutation of the sequence agactctgtct to
atattctatat reduced reporter activity to near basal levels (Fig.
4D). Inhibition of endogenous TGF- signaling also reduced
activity of the 2 wild type SBE reporter (Fig. 4E).
We next transiently transfected a shRNA construct targeting
Smad4 to determinewhether Smad4 is required forPUMApro-
moter activity. Because BL cells are renowned for their low
transfection rate, we monitored efficacy of Smad4 knockdown
by inhibition of the Smad4 dependent CAGA12-luciferase
reporter response to TGF- addition (Fig. 4F). We were able to
achieve a partial inhibition of CAGA12 activity and likewise
observed a small but significant decrease in PUMA activity (Fig.
4G). Taken together, these findings indicate that regulation of
the PUMA promoter by TGF- signaling ismost likely depend-
ent on Smad binding at the SBR at positions 1923 to 1885
and that proper regulation of the endogenous gene depends on
the correct repressive chromatin context.
PUMA Knockdown Retards TGF--induced Apoptosis—To
determine the functional consequence of PUMA induction by
TGF-, we used lentiviral transduction of shRNA constructs to
stably knockdownPUMA inBL30 cells. Transducing BL30 cells
with a combination of two commercially available shRNA con-
structs (shRNA1  2) reduced the basal and TGF--inducible
PUMA levels to below the background levels observed in the
control line (Fig. 5A). Two PUMA knockdown stable cell pools
(shRNA1 2#1 and shRNA1 2#2) were analyzed for apopto-
sis induction by TGF- using propidium iodide staining and
flow cytometry. Knockdown of PUMA resulted in a significant
reduction in the amount of apoptosis induction by TGF- after
24 h of treatment (Fig. 5B). We noted, however, that at later
time points (48 h) there was little discernable difference
between apoptosis induction in control versus PUMA knock-
down cell lines (data not shown). We therefore carried out a
more detailed kinetic analysis of early apoptosis induction
using PARP cleavage as a measure (Fig. 5C, top panel). The
Western blots revealed that although all lines retained equiva-
lent TGF- signaling, shown by equal levels of phosphorylation
of the receptor regulated Smad2, the apoptotic response in
PUMAknockdown lines was retardedwhen comparedwith the
control line, 22 and 18% PARP cleavage in the knockdown lines
after 8 h of treatment compared with 50% (summarized in the
graph shown in Fig. 5C, bottom panel).
TGF- Induces Apoptosis and PUMA Expression in E-Myc
Murine Lymphoma Lines—Given that PUMA expression levels
in the stable knockdown cell lines were reduced to below the
basal levels detected in untreated controls (Fig. 5A), the lack of
any significant effect on the percentage of apoptotic cells at
later time points is unlikely to be a consequence of the incom-
plete inhibition of PUMA induction in response to TGF-.
However, to exclude this possibility, we extended our study to
compare wild type and Puma null murine B-lymphoma cells.
E-Myc murine lymphoma lines are a model of BL. We first
determinedwhether isolatedwild type E-Myc lymphoma cells
undergo apoptosis in response to TGF- addition in vitro.
Annexin V staining of E-Myc cells revealed TGF--induced
cell death after 24 h of treatment (Fig. 6A). Apoptosis was con-
firmed by cleavage of PARP in TGF--treated wild type lym-
phoma cells (Fig. 6B). Cell death in response to TGF- was
dependent on the TGF- type I receptor ALK5 because pre-
treatment of lymphoma cells with SB-431542 inhibited death
induced by TGF- but had no effect on the cellular response to
the DNA damage-inducing agent etoposide (Fig. 6, C and D).
Apoptosis was inhibited by overexpression of BCL-2 in murine
lymphoma lines, indicating the involvement of the intrinsic
FIGURE 4. hPUMA promoter SBR luciferase reporter constructs. A and B,
transient transfection of CA46 BL cells with control reporter vector pBV-lucif-
erase (pBV-luc) or pBV containing the human PUMA promoter sequence
spanning2 kb upstream from the transcription start site (pBV-PUMA FragE
(31)). Transfected cells were treated with 5 ng/ml TGF- (A) or 10 M
SB-431542 (B) as indicated. C, wild type and mutant SBE reporter plasmids
were generated by cloning 2 concatemerized oligonucleotides of the
sequences shown into the pGL3-promoter vector (Promega). D and E, the
wild type SBE (pGL3–2WT SBE) and the mutant SBE (pGL3–2xMut SBE)
reporter constructs were assayed following exogenous TGF- addition (D) or
addition of SB-431542 (E) as indicated. F and G, CAGA12 (F) or pGL3–2WT
SBE (G) constructs were transfected into CA46 cells with either nonsilencing
vector (ns) or shRNA vector targeting Smad4. After 48 h, the transfections
were left untreated or treated with 5 ng/ml TGF-. Transfection results
throughout are expressed as the means ( S.D.) (n  3) luciferase reporter
activity relative to untreated control samples (set at 1). All data shown are
normalized to either co-transfected Renilla luciferase or -galactosidase
activity.
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apoptosis pathway (Fig. 6, E and F). In addition, TGF- treat-
ment resulted in induction of Puma shown by quantitative RT-
PCR (Fig. 6G) and by Western blot (Fig. 6H). These data indi-
cate that wild type murine E-Myc lymphoma cells mimic the
response of human BL cell lines to TGF- and undergo ALK5-
dependent intrinsic apoptosis involving PUMA induction.
PUMA Is Required for Efficient Apoptosis Induction in
E-Myc Lymohoma Lines—shRNA knockdown of PUMA in
human BL cell lines delayed the onset of apoptosis in response
to TGF- (Fig. 5C). We observed a similar correlation in the
murine E-Myc line 16, which had slower Puma RNA induc-
tion afterTGF- addition (Fig. 7A) and lower levels of apoptosis
by 12 h of TGF- treatment (Fig. 7B). However, to definitively
investigate the role of PUMA in this response, we compared the
response of wild type E-Myc cell lines with Puma null lines
(Puma/) to TGF-. All lines responded to TGF- because
they showed similar levels of Smad2 phosphorylation following
exogenous TGF- addition (Fig. 7C). When the effects of
TGF- treatment were directly compared in wild type versus
Puma null cells, there were significantly fewer apoptotic Puma
null cells than apoptotic wild type cells at early time points
following exposure to TGF- (Fig. 7D) but not at later time
points (Fig. 7E), thus confirming the data obtained in humanBL
lines. PUMA is therefore selectively required for efficient, rapid
TGF--induced apoptosis.
DISCUSSION
In this study we demonstrate a direct link between pro-apo-
ptotic TGF- signaling and transcriptional up-regulation of the
apoptosis activator PUMA in c-Myc-driven B-cell lymphomas.
FIGURE 5. Knockdown of PUMA retards TGF--induced apoptosis in BL lines. A, independent stable cell lines expressing nonsilencing (Scrambled) or shRNAs
targeted against PUMA (shRNA1 2#1 and shRNA1 2#2)were generatedby lentiviral infection of BL30 cells. Real timeqPCRwas used to demonstrate the efficacy
of knockdown of PUMA in stable BL30 cells in untreated cells and cells treated for 2 h with TGF-. Mean relative amounts of PUMA RNA are expressed after normal-
izationto18SrRNAlevels.B,determinationofapoptosisbypropidiumiodide(PI) stainingandflowcytometryfollowing24hTGF- treatmentofthecell linesdescribed
in A. Statistical analysis was performed using Student’s t test. C, Western blot analysis of apoptosis (PARP) and TGF- signaling (p-Smad2) in BL30 stable cell lines
described inA and Bduring a time course of TGF- treatment. AWestern blot for actin is included as a loading control. The amount of cleaved PARP as a percentage
of total PARP determined by densitometry is indicated above each lane and is summarized in the graph shownbelow.
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PUMA was required for the effective, early induction of apo-
ptosis in both human andmurine lymphomas, but its induction
does not require c-Myc activity. The involvement of PUMA in
this process was demonstrated by stable knockdown of PUMA
in human BL, but to be confident that we could assess the effect
of complete lack of PUMA on TGF--induced apoptosis, we
extended our analysis to compare E-Myc lymphomas derived
from Puma null and wild type mice. We believe this is the first
FIGURE 6.Murine E-Myc lines are sensitive to TGF--induced apoptosis. A, murine E-Myc cell lines were analyzed by annexin V staining and flow
cytometry for their response to TGF- treatment (24 h). B, Western blot analysis of lysates from E-Myc cell lines showing cleavage of PARP following
12 h of treatment with TGF-. C and D, murine E-Myc line 4 (C) and line 8 (D) were treated for 24 h with TGF- or etoposide (5 g/ml) in the presence
or absence of a TGF- RI (ALK5) inhibitor, SB-431542 (SBi, 10 M). Apoptosis induction was determined by annexin V staining and flow cytometry and is
expressed as the mean ( S.D.) percentage induction above background levels. E and F, E-Myc cell lines stably transfected with empty vector (pMIH)
or Bcl-2 expressing vector (pMIH-Bcl-2) were analyzed by Western blot for Bcl-2 expression (E) and by annexin V staining (F) for susceptibility to TGF-
induced apoptosis following 24 h of treatment. G, wild type E-Myc cell lines were left untreated or treated with TGF- for 2 h and analyzed by qRT-PCR
for Puma mRNA expression levels. The results are expressed as the mean fold mRNA level relative to the untreated control. H, Western blot analysis of
PUMA expression in untreated (Con) wild type E-Myc lines or lines treated for 6 h with TGF-. A blot for tubulin is included as a loading control. DMSO,
dimethyl sulfoxide.
TGF- Induces PUMA inMyc-driven Lymphomas
FEBRUARY 15, 2013•VOLUME 288•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 5205
 at G
lasgow
 U
niversity Library on January 29, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
demonstration that murine E-Myc lymphomas are suscepti-
ble to TGF--induced apoptosis. Stroma-derived TGF- from
infiltrating immune cells has previously been reported tomedi-
ate a tumor suppressor function in vivo by inducing senescence
of E-Myc lymphoma cells (32). Our data suggest that in addi-
tion to senescence, TGF- expressed in the tumor microenvi-
ronment would also be likely to induce ALK5-dependent apo-
ptosis of malignant cells.
We report that a complete loss of PUMA in knock-out
E-Myc cells and knockdownof PUMA inhumanBL cells delay
cell death but do not ultimately prevent cells from undergoing
apoptosis. This observation is consistent with the idea that
PUMA has a role in priming cells for apoptosis as part of a
polygenic apoptotic response that may have a role in “sensing”
the apoptotic signal (33). As well as PUMA activation, the apo-
ptotic program involves the early activation of BIK in human
cells followed by down-regulation of BCL-XL (3). Such changes
in expression levels of the other BCL-2 family members pre-
sumably are sufficient to induce apoptosis, albeit with slower
kinetics. As predicted previously, we have seen no TGF--de-
pendent activation of BIK in mouse cells because the Smad-
binding element identified within the human BIK promoter is
not conserved (Ref. 3 and Fig. 3). BCL-XL, however, is down-
regulated in response to TGF- in murine E-Myc lymphoma
cells.6 This suggests that loss of BCL-XL function may ulti-
mately be sufficient in murine lymphoma to induce apoptosis.
but we cannot exclude the possibility that other BH3-only sen-
sitizers might also be induced in response to TGF- in the
mouse.
Themechanismof PUMA induction byTGF- in this system
requires some further analysis. We have determined that
6 L. C. Spender, unpublished observations.
FIGURE 7. E-Myc cell lines derived from Puma/ mice exhibit a delayed apoptotic response to TGF-. A, kinetics of TGF--mediated Puma RNA
induction inwild typeE-Myc lymphoma lines asdeterminedbyqPCR.B, early kinetics of apoptosis induction inwild typeE-Myc lymphoma lines asmeasured
by annexin V staining. C, Western blot analysis of TGF- signaling (pSmad2) and PUMA expression inWT and Puma null (Puma/) E-Myc lymphoma lines in
uninduced or induced conditions (6 h of treatment with TGF-). A blot for total Smad2/3 is included as a loading control. D and E, apoptosis induction above
background in lymphoma lines derived fromWT (n 4) and homozygous Puma null (Puma/) (n 4) mice following 6 h (D) and 24 h (E) of treatment with
TGF-. Apoptosis induction above backgroundwas determined by annexin V staining and flow cytometry. Themean apoptosis values are shown as bars, and
the p values were determined by Mann-Whitney statistical analysis.
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PUMA is induced even in the presence of protein synthesis
inhibitors, demonstrating that de novo protein synthesis is not
required for PUMA transcriptional up-regulation in BL cells
and also that in vivo, activated Smad3/Smad4 is recruited
directly to a SBRwithin the endogenous promoter. Constitutive
activity of the isolated putative Smad-binding region was
dependent on consensus SBE sequences in transient transfec-
tion assays, and it was partially inhibited by blocking endoge-
nous TGF- signaling and lowering Smad4 levels; however,
exogenous addition of ligand did not induce its activity. These
data suggest that chromatin structure and/or transcriptional
repressors may be important for correct regulation of the
endogenous gene.
The induction of PUMA-mediated apoptosis by TGF-
superfamily members has been described previously in oligo-
dendrocytes (induced by activin A but not by TGF-) and by
TGF- in a gastric cancer cell line. In both cases, however,
elevated PUMA levels were dependent on p53 familymembers.
A p53 family inhibitor pifithrin- blocked activin A-induced
apoptosis of oligodendrocytes (34), whereas TGF--induced
apoptosis of SNU-16 gastric cancer cells was due to the induc-
tion of p73, which presumably bound p53 consensus sequences
on the PUMA promoter (35). In these studies, there was no
evidence that Smads were recruited directly to the PUMA pro-
moter as detected in BL cells. However, it is possible that a p53
family member might still be involved in TGF--induced reg-
ulation of PUMA in our system by acting as co-activators with
the Smad proteins. Smads are regulated by numerous post-
translational modifications and cooperate with many other
transcription factors (including the p53 family) to regulate gene
transcription, thus ensuring that their function is highly con-
text dependent (6). p53 and p73, for example, directly bind
Smads 2 and 3 and can stabilize Smad-DNA complexes on spe-
cific gene promoters (36). It would seem unlikely that p53 is
involved in TGF-/Smad activation of the PUMA promoter
because all but one of the BL cell lines used in this study express
mutant p53 (BL2 cells express wild type p53 (37)). Transcripts
of p73 are expressed in BL cells but are not increased by TGF-
treatment.6
So far, direct activation of PUMA by TGF- has been dem-
onstrated in B-cell subsets (lymphomas and human primary
centroblasts) but not in murine embryonic fibroblasts or
HaCaT epithelial cells. The reason for the selective response in
certain cell types is currently unclear. It is possible that the
proteome of B-cells uniquely allows PUMA activation in
response to TGF-. The panel of BL cells examined here lack
expression of SLUG, a transcription factor involved in the
repression of PUMA transcription.6 Expression of SLUG in
hematopoietic progenitor cells is responsible for protecting
progenitor cells from DNA damage-induced apoptosis by
repressing p53-mediated PUMA transcription (38). TGF-
may be able to induce PUMA in B-cells by virtue of its lack of
repression. Another possibility is that PUMA is regulated by a
B-cell-specific transcription factor in conjunction with TGF--
activated Smads.
A study published during the preparation of this manu-
script implicates the activation status of B-cells as a factor in
PUMA production, with PUMA being involved in the regu-
lation of antigen specific memory B-cells both in vitro and in
vivo. PUMA protein expression was detected in histological
sections of human lymph nodes, potentially as a result of
antigenic stimulation, because stimulation of cells in vitro
with the mitogens Staphylococcus aureus Cowan or LPS, or
alternatively following ligation of the B-cell receptor or
CD40, all resulted in up-regulation of PUMA. Provided suf-
ficient pro-survival signals are received to maintain BCL-XL
levels, the effect of PUMA induction in this system is negated
(26). The mechanism of PUMA induction was not identified
by Clybouw et al. (26) but was determined to be independent
of p53 because p53/ B-cells produced similar levels of
PUMA to wild type cells.
Given our finding that PUMA is induced in vitro by TGF-
treatment of centroblasts (Fig. 2) and that active, phospho-
rylated Smad2 is detectable throughout the germinal center
(3), we can speculate that PUMA detected in the tonsil sec-
tions could result from TGF- signaling. This may arise as a
result of the establishment of an activation-induced TGF--
autocrine feedback loop (39). There are several lines of evi-
dence to support this hypothesis. TGF- mRNA is detecta-
ble in both resting and activated B-cells (40). Stimulation of
human tonsil cells with S. aureus Cowan does not signifi-
cantly affect TGF- mRNA levels but does result in a 7-fold
increase in TGF- protein secretion (41). Similarly, LPS
treatment of murine splenocytes induces the production of
bioactive TGF- (42). The induction of TGF- in activated
B-cells is thought to limit the expansion of the activated
population. Without this autoregulatory feedback loop
severe autoimmunity develops (43, 44). Our data presented
here indicate that regulation of PUMA plays a role in the
apoptotic response of B-cells exposed to TGF- and suggest
that this may play a role in the efficient control of activated
B-cell proliferation. This notion may provide an explanation
for the elevated levels of IgA observed in Puma null mice (45)
because IgA class switching is promoted by TGF- (46). The
intriguing possibility that activation-induced PUMA pro-
duction occurs because of an autocrine TGF-/ALK5/Smad
pathway and the relative role, mechanisms, and kinetics of
regulation of BCL-XL and other BCL-2 family members in
B-cell survival warrants further investigation.
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